Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alteplase; Aspirin; Eptifibatide; Tinzaparin sodium
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions
- Acronyms CATALIST
- 04 Feb 2013 Biomarkers information updated
- 22 Jul 2011 Actual end date changed from Dec 2009 to Jul 2011 as reported by ClinicalTrials.gov.
- 22 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.